Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories Inc reports results for the quarter ended in June - Earnings Summary

* Mesa Laboratories Inc  MLAB.OQ  reported a quarterly
adjusted
loss of 10 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 2 cents per share.
    * Revenue rose 0.4% to $50.65 million from a year ago;
analysts
expected $51.85 million. 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Mesa Laboratories Inc shares had fallen by 1.9% this
quarter and
lost 24.2% so far this year.
    * Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $152.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 01:34 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.02          -0.10          Missed
 Mar. 31 2023      0.37           0.11           Missed
 Dec. 31 2022      0.14           0.08           Missed
 Sep. 30 2022      -0.31          0.24           Beat

Recent news on Mesa Laboratories

See all news